Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Prospective, Open-label Trial of Two ABC/3TC Based Regimens in Late Presenter naïve Patients (CD4 <200 Cells/µL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by University of Modena and Reggio Emilia
Sponsor:
Information provided by (Responsible Party):
Cristina Mussini, University of Modena and Reggio Emilia
ClinicalTrials.gov Identifier:
NCT01900106
First received: July 5, 2013
Last updated: October 25, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)